• Users Online: 364
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2016  |  Volume : 3  |  Issue : 3  |  Page : 116-121

Benefits of preoperative use of statins in minimizing the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting surgery for unstable angina


1 Department of Anaesthesia and Surgical Intensive Care, Alexandria University Hospitals, Alexandria, Egypt
2 Department of Cardiology, Alexandria University Hospitals, Alexandria, Egypt
3 Department of Anaesthesia and Surgical Intensive Care, Damanhur Teaching Hospital, Damanhur, Egypt

Correspondence Address:
Mohamed S Elhadidy
Department of Anesthesia, Alexandria University Hospital, Alexandria, 21648
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2356-9115.193410

Rights and Permissions

Background Several drug therapies and perioperative techniques have been proposed to prevent episodes of atrial fibrillation (AF) after cardiac surgery. Preoperative preparation and evaluation by the anesthesiologist in conjugation with the cardiologist and the surgeon is a new important role. These conjugations augment preoperative treatment and reduce much of the perioperative morbidity and mortality. Aim The aim of this work was to assess preoperative use of two regimens of statins in minimizing the incidence of postoperative AF in patients undergoing coronary artery bypass grafting operation. Patients and methods Written informed consent was obtained from all patients before the operation as regards their acceptance to be subjected to the procedure after a full explanation of its benefits and potential risks. Diagnosis of unstable angina was confirmed and patients were randomly allocated into three equal groups using the closed envelop method, according to the statin management protocol. Group I (n=15) (the control group) included patients who did not receive any statins before the operation. Group II included (n=15) patients who received atorvastatin 80 mg orally once daily starting 7 days before operation (including the morning of the operation). Group III (n=15) included patients who received atorvastatin 80 mg orally once on the day before the operation and in the morning of the day of the surgery. On the first postoperative day, all patients received atorvastatin 40 mg orally once daily and continued for 30 days postoperatively. Incidence of postoperative in-hospital AF was assessed. AF is defined as episodes of AF that lasted more than or equal to 5 min that was registered by the monitoring system and/or on a rhythm strip or 12-lead ECG and the incidence of episodes that required intervention for angina or hemodynamic compromise. Results There was no significant difference between the three groups as regards the incidence, onset, and duration of in-hospital AF (P>0.05). There were no reported cases of AF after discharge from the hospital until day 30 postoperatively (12-lead ECG was performed during every outpatient visit and on day 30 postoperatively). Moreover, there was a significantly decreased incidence of AF on increasing the duration of preoperative statin use (studied using the Mann–Whitney test). Conclusion The incidence of postoperative AF reduced in patients who received atorvastatin 80 mg for 7 days before operation. However, two doses of atorvastatin 80 mg before operation failed to reduce the incidence of postoperative AF.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed920    
    Printed18    
    Emailed0    
    PDF Downloaded62    
    Comments [Add]    

Recommend this journal